PHAT — Phathom Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $567.12m
- $934.14m
- $175.11m
Phathom Pharma up after submitting additional data for acid blocker drug
Brief: Phathom Pharmaceuticals Inc submits 6-Month Stability Data In Support Of Erosive Gerd New Drug Application
Phathom Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Phathom Pharmaceuticals Q2 Net Income USD -40.965 Million
Phathom Pharmaceuticals Inc expected to post a loss of 100 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Precision Optics, Tesla, airline stocks
Phathom shares up as FDA sets action date for inflammation drug
Brief: Phathom Pharmaceuticals Announces FDA Acceptance Of NDA Resubmission For Erosive GERD
Brief: Phathom Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Brief: Phathom Pharmaceuticals Announces Proposed Public Offering Of Common Stock
Brief: Phathom Pharmaceuticals Resubmits Erosive Gerd New Drug Application To FDA
Brief: Phathom Pharmaceuticals Reports First Quarter 2023 Results
Phathom Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Phathom Pharmaceuticals Inc expected to post a loss of $1.26 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AMC Entertainment, Trilogy Metals, Nogin
U.S. STOCKS ON THE MOVE-Duckhorn Portfolio, BullFrog AI, VBI Vaccines
Phathom Pharma rises on plans to resubmit application for inflammation drug
Phathom Pharma rises on plans to resubmit application for inflammation drug
U.S. STOCKS ON THE MOVE-Moderna, Genie Energy, Merck & Co